tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MBIO Stock Latest News

Mustang Bio announces vision for CAR T-Cell therapy platform expansion
The FlyMustang Bio announces vision for CAR T-Cell therapy platform expansion
22d ago
MBIO
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
PremiumPress Releases
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
22d ago
MBIO
Mustang Bio files to sell common stock, warrants, no amount given
PremiumThe Fly
Mustang Bio files to sell common stock, warrants, no amount given
1M ago
MBIO
Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
1M ago
MBIO
Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
PremiumPress Releases
Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
1M ago
MBIO
Mustang Bio announces publication of data from Phase 1 trial of MB-101
PremiumThe FlyMustang Bio announces publication of data from Phase 1 trial of MB-101
1M ago
MBIO
Mustang Bio Evaluates Sale of Facility Amid Security Reviews
PremiumCompany Announcements
Mustang Bio Evaluates Sale of Facility Amid Security Reviews
2M ago
8K
MBIO
Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
PremiumPress Releases
Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
3M ago
MBIO
Mustang Bio files to sell 2.74M shares of common stock for holders
PremiumThe Fly
Mustang Bio files to sell 2.74M shares of common stock for holders
4M ago
MBIO
Mustang Bio presents updated Phase 1/2 data for MB-106
PremiumThe Fly
Mustang Bio presents updated Phase 1/2 data for MB-106
4M ago
MBIO
Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting
PremiumPress Releases
Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting
4M ago
MBIO
Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
5M ago
MBIO
Is MBIO a Buy, Before Earnings?
PremiumPre-EarningsIs MBIO a Buy, Before Earnings?
5M ago
MBIO
Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting
PremiumPress Releases
Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting
6M ago
MBIO
Mustang Bio to present MB-106 CD20-targeted CAR-T data
PremiumThe Fly
Mustang Bio to present MB-106 CD20-targeted CAR-T data
6M ago
MBIO
ITOT ETF: An Ideal Building Block for New Investors 
PremiumStock Analysis & Ideas
ITOT ETF: An Ideal Building Block for New Investors 
6M ago
BLK
SPX
Mustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Mustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6M ago
MBIO
Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6M ago
MBIO
Mustang Bio sells 2.59M shares at $1.70 in registered direct offering
PremiumThe Fly
Mustang Bio sells 2.59M shares at $1.70 in registered direct offering
6M ago
MBIO
Mustang Bio announces FDA acceptance of IND application for MB-109
PremiumThe FlyMustang Bio announces FDA acceptance of IND application for MB-109
6M ago
MBIO
Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma
PremiumPress Releases
Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma
6M ago
MBIO
option delistings on September 25th
PremiumThe Fly
option delistings on September 25th
7M ago
MFH
NYC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >